Articles in Scholarly Journals [Incomplete List]

1. Novel platinum pyridinehydroxamic acid complexes: Synthesis, characterisation, X-ray crystallographic study and nitric oxide related properties
   Polyhedron, 2007
2. Synthesis, characterization and biological activity of copper complexes with pyridoxal thiosemicarbazone derivatives. X-ray crystal structure of three dimeric complexes
   Journal of Inorganic Biochemistry, vol. 98, no. 2, pp. 301–312, 2004
3. Solution, solid state and biological characterization of ruthenium(III)-DMSO complexes with purine base derivatives
   Journal of Inorganic Biochemistry, vol. 98, no. 2, pp. 393–401, 2004
4. Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir
   Journal of Inorganic Biochemistry, vol. 98, no. 8, pp. 1385–1390, 2004
5. Journal of Medicinal Chemistry, vol. 47, no. 5, pp. 1110–1121, 2004
6. Investigational New Drugs, vol. 21, no. 4, pp. 401–411, 2003
7. Distinct Effects of Dinuclear Ruthenium(III) Complexes on Cell Proliferation and on Cell Cycle Regulation in Human and Murine Tumor Cell Lines
   Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 2, pp. 725–732, 2003
8. Molecular structure, solution chemistry and biological properties of the novel [ImH][trans-IrCl4(Im)(DMSO)], (I) and of the orange form of [(DMSO)2H][trans-IrCl4(DMSO)2], (II), complexes
   Journal of Inorganic Biochemistry, vol. 95, no. 1, pp. 37–46, 2003
9. Tumour cell uptake of the metastasis inhibitor ruthenium complex NAMI-A and its in vitro effects on KB cells
   Cancer Chemotherapy and Pharmacology, vol. 50, no. 5, pp. 405–411, 2002
10. Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A
    British Journal of Cancer, vol. 86, no. 6, Article ID 6600176, 5 pages, 2002
11. Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA = 1,3,5-triaza-7-phosphaadamantane)Electronic supplementary information (ESI) available: synthesis, 31P{1H}, 1H, 13C NMR characterisation and elemental analysis of 1 and 2. See http://www.rsc.org/suppdata/cc/b2/b210102e/
    Chemical Communications, no. 2, pp. 264–265, 2002
12. Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[?trans-RuCl4(Me2SO)?2(µ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation
    Journal of Inorganic Biochemistry, vol. 79, no. 1-4, pp. 173–177, 2000
13. Modification of cell cycle and viability of TLX5 lymphoma in vitro by sulfoxide-ruthenium compounds and cisplatin detected by flow cytometry
    Chemico-Biological Interactions, vol. 113, no. 1, pp. 51–64, 1998
14. Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: The crystal structure of [ImH][-RhCl(Im)] (Im=imidazole)
    Inorganica Chimica Acta, vol. 273, no. 1-2, pp. 62–71, 1998
15. Treatment of residual metastases with Na[trans-RuCl4(DMSO)lm] and ruthenium uptake by tumor cells
    Anti-Cancer Drugs, vol. 7, no. 6, pp. 697–702, 1996
16. Reduction of Lung Metastases by Na[trans-RuCl4(DMSO)Im] is not Coupled With the Induction of Chemical Xenogenization
    Metal-Based Drugs, vol. 3, no. 2, pp. 67–73, 1996
17. Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complex
    International Journal of Cancer, vol. 68, no. 1, pp. 60–66, 1996
18. Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition
    Chemico-Biological Interactions, vol. 95, no. 1-2, pp. 109–126, 1995